In summary, our study demonstrated for the first time that NNMT is overexpressed in breast carcinoma and that a high level of NNMT expression correlates with poor survival and an unfavorable therapy response in patients who received chemotherapy. The gene discussed is NNMT; the disease is breast carcinoma.